A Narrative Review of the State of the Art of CCR4-Based Therapies in Cutaneous T-Cell Lymphomas: Focus on Mogamulizumab and Future Treatments. This evidence concerns the gene CCR4 and primary cutaneous T-cell non-Hodgkin lymphoma.